Tim Evans
Stock Analyst at Wells Fargo
(2.39)
# 2,436
Out of 4,735 analysts
23
Total ratings
72.73%
Success rate
4.35%
Average return
Main Sectors:
Stocks Rated by Tim Evans
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Market Perform | $38 → $35 | $347.52 | -89.93% | 3 | Feb 28, 2018 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $348.95 | -19.76% | 2 | Feb 28, 2018 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $353.86 | -20.87% | 2 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $141.31 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $105 → $112 | $344.69 | -67.51% | 4 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | $88 → $86 | $152.65 | -43.66% | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | $175 | $243.99 | -28.28% | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $78.75 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | $90 | $244.11 | -63.13% | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,324.48 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $60.07 | - | 2 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $152.57 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.73 | - | 1 | May 3, 2017 |
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: $38 → $35
Current: $347.52
Upside: -89.93%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $348.95
Upside: -19.76%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $353.86
Upside: -20.87%
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $141.31
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: $105 → $112
Current: $344.69
Upside: -67.51%
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: $88 → $86
Current: $152.65
Upside: -43.66%
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: $175
Current: $243.99
Upside: -28.28%
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $78.75
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: $90
Current: $244.11
Upside: -63.13%
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,324.48
Upside: -
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $60.07
Upside: -
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $152.57
Upside: -
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $1.73
Upside: -